相似文献
1
Motivators for Alzheimer's disease clinical trial participation.阿尔茨海默病临床试验参与的动机。
Aging Clin Exp Res. 2018 Feb;30(2):209-212. doi: 10.1007/s40520-017-0771-2. Epub 2017 May 18.
2
Why participate in an Alzheimer's disease clinical trial? Is it of benefit to carers and patients?为什么要参与阿尔茨海默病临床试验？这对护理人员和患者有益吗？
Int Psychogeriatr. 2003 Jun;15(2):149-56. doi: 10.1017/s1041610203008834.
3
Carer impressions of participation in Alzheimer's disease clinical trials: what are their hopes? And is it worth it?护理人员对参与阿尔茨海默病临床试验的看法：他们的期望是什么？这样做值得吗？
Int Psychogeriatr. 2002 Mar;14(1):39-45. doi: 10.1017/s1041610202008268.
4
"From Victimhood to Warriors": Super-researchers' Insights Into Alzheimer's Disease Clinical Trial Participation Motivations.从受害者到勇士：超级研究员对阿尔茨海默病临床试验参与动机的见解。
Gerontologist. 2020 May 15;60(4):693-703. doi: 10.1093/geront/gnz096.
5
Identifying motivations and barriers to patient participation in clinical trials.确定患者参与临床试验的动机和障碍。
J Cancer Educ. 2006 Winter;21(4):237-42. doi: 10.1080/08858190701347838.
6
Patients' perspectives and motivators to participate in clinical trials with novel therapies for rheumatoid arthritis.患者对于参与类风湿关节炎新型疗法临床试验的观点及动机。
J Med Life. 2009 Apr-Jun;2(2):227-31.
7
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.优势遗传性阿尔茨海默病网络试验单位（DIAN-TU）：试验满意度和对未来临床试验的态度。
J Prev Alzheimers Dis. 2024;11(3):558-566. doi: 10.14283/jpad.2024.61.
8
Study partners should be required in preclinical Alzheimer's disease trials.临床前阿尔茨海默病试验应要求有研究伙伴。
Alzheimers Res Ther. 2017 Dec 6;9(1):93. doi: 10.1186/s13195-017-0327-x.
9
Involving South Asian patients in clinical trials.让南亚患者参与临床试验。
Health Technol Assess. 2004 Oct;8(42):iii, 1-109. doi: 10.3310/hta8420.
10
Patient and carer views on participating in clinical trials for prodromal Alzheimer's disease and mild cognitive impairment.前驱期阿尔茨海默病和轻度认知障碍临床试验中患者和照护者参与意愿的研究。
Int J Geriatr Psychiatry. 2014 Jan;29(1):22-31. doi: 10.1002/gps.3958. Epub 2013 May 6.
引用本文的文献
1
Reflecting upon Session 8 of the 2023 dementia care summit: Diversity beyond outreach, recruitment, and retention.反思2023年痴呆症护理峰会的第八场会议：超越外展、招募和留用的多样性。
Alzheimers Dement. 2025 Sep;21(9):e70661. doi: 10.1002/alz.70661.
2
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study.痴呆前参与者的招募：纵向淀粉样蛋白-PET 研究中的主要入组障碍。
Alzheimers Res Ther. 2023 Nov 2;15(1):189. doi: 10.1186/s13195-023-01332-4.
3
Experiences of and recommendations on clinical trial design in Alzheimer's disease from the participant's point of view: a mixed-methods study in two clinical trial centers in the Netherlands.从参与者的角度出发，对阿尔茨海默病临床试验设计的经验和建议：荷兰两个临床试验中心的混合方法研究。
Alzheimers Res Ther. 2023 Apr 4;15(1):72. doi: 10.1186/s13195-023-01190-0.
4
Barriers and facilitators to the recruitment of disabled people to clinical trials: a scoping review.将残疾人招募到临床试验中的障碍和促进因素：范围综述。
Trials. 2023 Mar 8;24(1):171. doi: 10.1186/s13063-023-07142-1.
5
A Qualitative Examination of Knowledge, Experiences, and Considerations of PET Brain Scan Participation Among Older Black and Latino Adults.对老年黑人和拉丁裔成年人参与正电子发射断层扫描（PET）脑扫描的知识、经验和考虑因素的定性研究
J Alzheimers Dis. 2023;91(3):961-976. doi: 10.3233/JAD-220861.
6
Non-oncology clinical trial engagement in a nationally representative sample: Identification of motivators and barriers.全国代表性样本中的非肿瘤学临床试验参与情况：动机与障碍的识别
Contemp Clin Trials. 2022 Apr;115:106715. doi: 10.1016/j.cct.2022.106715. Epub 2022 Feb 22.
7
Experiences of Participation in a Multimodal Preventive Trial MIND-AD Among Persons with Prodromal Alzheimer's Disease: A Qualitative Study.参与前驱期阿尔茨海默病患者多模式预防性试验MIND-AD的经历：一项定性研究
J Multidiscip Healthc. 2022 Jan 29;15:219-234. doi: 10.2147/JMDH.S345607. eCollection 2022.
8
Recruiting Persons with Dementia and Caregivers in a Clinical Trial: Dyads Perceptions.招募痴呆症患者及其照护者参与临床试验：双员感知。
West J Nurs Res. 2022 Jun;44(6):557-566. doi: 10.1177/01939459211008563. Epub 2021 Apr 17.
9
Alzheimer Disease Worries, Fears, and Stigma and Their Relationship to Genetic and Interventional Research Engagement.阿尔茨海默病的担忧、恐惧和污名及其与遗传和干预研究参与的关系。
Alzheimer Dis Assoc Disord. 2021;35(1):75-79. doi: 10.1097/WAD.0000000000000413.
10
Attitudes toward clinical trials across the Alzheimer's disease spectrum.阿尔茨海默病谱系中对临床试验的态度。
Alzheimers Res Ther. 2017 Oct 4;9(1):81. doi: 10.1186/s13195-017-0311-5.
本文引用的文献
1
2015 Alzheimer's disease facts and figures.2015 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2015 Mar;11(3):332-84. doi: 10.1016/j.jalz.2015.02.003.
2
Obstacles and opportunities in Alzheimer's clinical trial recruitment.阿尔茨海默病临床试验招募中的障碍与机遇
Health Aff (Millwood). 2014 Apr;33(4):574-9. doi: 10.1377/hlthaff.2013.1314.
3
Systematic review and meta-analysis to estimate potential recruitment to dementia intervention studies.系统评价和荟萃分析以估计痴呆症干预研究的潜在招募情况。
Int J Geriatr Psychiatry. 2014 May;29(5):515-25. doi: 10.1002/gps.4034. Epub 2013 Oct 10.
4
Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis.提高随机对照试验招募效果的方法：Cochrane 系统评价和荟萃分析。
BMJ Open. 2013 Feb 7;3(2). doi: 10.1136/bmjopen-2012-002360. Print 2013.
5
Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment.风险披露和临床前阿尔茨海默病临床试验入组。
Alzheimers Dement. 2013 May;9(3):356-359.e1. doi: 10.1016/j.jalz.2012.03.001. Epub 2012 Nov 8.
6
Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology.阿尔茨海默病治疗试验：欧盟/美国招募、保留和方法工作组报告。
J Nutr Health Aging. 2012 Apr;16(4):339-45. doi: 10.1007/s12603-012-0044-x.
7
Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials.解决阿尔茨海默病临床试验中成功招募和保留的挑战。
Alzheimers Res Ther. 2010 Dec 21;2(6):34. doi: 10.1186/alzrt58.
8
Recruitment of subjects into clinical trials for Alzheimer disease.招募受试者参加阿尔茨海默病的临床试验。
J Am Osteopath Assoc. 2010 Sep;110(9 Suppl 8):S43-9.
9
Barriers and facilitators of African American participation in Alzheimer disease biomarker research.非裔美国人参与阿尔茨海默病生物标志物研究的障碍和促进因素。
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24 Suppl(Suppl):S24-9. doi: 10.1097/WAD.0b013e3181f14a14.
10
What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies.哪些因素会影响随机对照试验的受试者招募？对由两家英国资助机构资助的试验的综述。
Trials. 2006 Apr 7;7:9. doi: 10.1186/1745-6215-7-9.
Zotero 插件